Medi-Tech Insights Get in touch

Global Liquid Biopsy Market Size, Share, Growth & Trends Report Segmented by Technology (NGS, dPCR), Biomarker (ctDNA, cfDNA, CTCs), Application (Lung, Breast, Colorectal, Prostate, Prenatal), Sample (Blood, Urine), Product & Service, End-user, Analysis & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Liquid Biopsy Market Snapshot (2026-2031)
    • Segment Overview
    • Regional Snapshot
    • Competitive In"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising global cancer incidence and growing demand for early cancer detection
          • Increasing adoption of precision medicine and targeted therapies
          • Advancements in NGS, PCR, and multi-omics technologies
          • Growing preference for minimally invasive diagnostic procedures
          • Expanding applications in treatment monitoring and recurrence detection
          • Increasing use of liquid biopsy in companion diagnostics and clinical trials
        • Restraints
          • Limited clinical validation and lack of assay standardization
          • High cost of advanced liquid biopsy and NGS-based testing
          • Reimbursement and regulatory approval challenges
          • Sensitivity limitations in detecting early-stage cancers
        • Opportunities
          • Expansion of multi-cancer early detection (MCED) testing
          • Growing demand for minimal residualease (MRD) monitoring
          • Increasing adoption across emerging healthcare markets
          • Integration of AI and bioinformatics for genomic interpretation
        • Key Market Trends
          • Growing focus on MRD and longitudinal cancer monitoring
          • Increasing strategic partnerships between pharma and diagnostics companies
          • Rising adoption of multi-omics liquid biopsy platforms
          • Expansion of blood-based cancer screening programs globally
        • Unmet Market Needs
        • Industry Speaks
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Product & Services, USD Billion
    • Introduction
    • Kits & Reagents
    • Instruments
    • Software & Services
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Technology, USD Billion
    • Introduction
    • Next-Generation Sequencing (NGS)
    • PCR & Digital PCR (dPCR)
    • Others
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Biomarker Type, USD Billion
    • Introduction
    • Circulating Tumor Cells (CTCs)
    • Circulating Tumor DNA (ctDNA)
    • Cell-Free DNA (cfDNA)
    • Exosomes/Microvesicles
    • Others
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Sample Type, USD Billion
    • Introduction
    • Blood
    • Urine
    • Others
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Application, USD Billion
    • Introduction
    • Oncology
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Prostate Cancer
      • Others
    • Non-Cancer Applications
      • Prenatal Testing
      • Transplant Monitoring
      • Infectious Diseases
      • Neurological Disorders
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By End User, USD Billion
    • Hospitals and Laboratories
    • Specialty Clinics
    • Academic and Research Centers
    • Others
  1. Global Liquid Biopsy Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction
    • North America Liquid Biopsy Market Size & Forecast (2024-2031), By Country, USD Billion
      • US
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Canada
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecaslion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Europe Liquid Biopsy Market Size & Forecast (2024-2031), By Country, USD Billion
      • UK
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Germany
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast,
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • France
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Italy
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Mand User (USD Billion)
      • Spain
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Europe
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Asia Pacific (APAamp; Forecast (2024-2031), By Country, USD Billion
      • China
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Japan
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • India
        • roduct & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Product & Services (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Biomarker Type (USD Billion)
        • Market Size & Forecast, By Sample Type (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Latin America (LATAM) Liquid Biopsy Market Size & Forecast (2024-2031), USD Billion
      • Market Siz & Services (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Biomarker Type (USD Billion)
      • Market Size & Forecast, By Sample Type (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Middle East & Africa (MEA) Liquid Biopsy Market Size & Forecast (2024-2031), USD Billion
      • Market Size & Forecast, By Product & Services (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Biomarker Type (USD Billion)
      • Market Size & Forecast, By Sample Type (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
  1. Global Liquid Biopsy Market, Clinical Utility Analysis (Qualitative)
    • Early Cancer Screening
    • Therapy Selection
    • Treatment Monitoring
    • Recurrence Monitoring
    • MRD Monitoring
 
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2023-2026)
        • New Product/Service Launch
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  1. Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Guardant Health, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Exact Sciences Corporation
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Other Prominent Players
Note: *Indicative list **For listed companies

Related Reports

View All Research Reports